9MW1411

· Mabwell (Shanghai) Bioscience Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 9MW1411, covering 2022-04-21 to 2022-04-21. Get the full timeline:

Most recent: Clinical Trial Update: A Phase Ⅱ Clinical Study of 9MW1411 Injection in Acute Bacterial Skin and Skin Structure Infections [Phase 2]